REGN - REGENERON PHARMACEUTICALS, INC.

QQQ $ 452.78 $ 0.25 (0.06 %)

DIA $ 408.38 $ 1.05 (0.26 %)

SPY $ 545.04 $ 0.37 (0.07 %)

TLT $ 99.98 $ 0.60 (0.6 %)

GLD $ 231.29 $ 0.03 (0.01 %)

Previous Close

$ 1131.5

Open

$ 1,134.06

Bid

$ 1,131.99 x 101

Ask

$ 1,145.89 x 175

Day's Range

$ 1,134.06 - $ 1,150.49

52 Week Range

$ 769.19 - $ 1,211.20

Volume

616,625

Average Volume

Market Cap

124.73B

Beta (5Y Monthly)

$ 0.53

PE Ratio (TTM)

$ 28.86

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-05-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-06-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-03-2022	06-30-2022	10-Q
10	05-04-2022	03-31-2022	10-Q
11	02-07-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-08-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-05-2020	03-31-2020	10-Q
19	02-07-2020	12-31-2019	10-K
20	11-05-2019	09-30-2019	10-Q
21	08-06-2019	06-30-2019	10-Q
22	05-07-2019	03-31-2019	10-Q
23	02-07-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-03-2018	03-31-2018	10-Q
27	02-08-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-03-2017	06-30-2017	10-Q
30	05-04-2017	03-31-2017	10-Q
31	02-09-2017	12-31-2016	10-K
32	11-04-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	02-11-2016	12-31-2015	10-K
36	11-04-2015	09-30-2015	10-Q
37	08-04-2015	06-30-2015	10-Q
38	05-07-2015	03-31-2015	10-Q
39	02-12-2015	12-31-2014	10-K
40	11-04-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Reiterates Neutral on Re...
09/09/2024 16:06:39

Cantor Fitzgerald analyst Olivia Brayer reiterates Regeneron Pharmaceuticals (NASDAQ:REGN) with a Neutral and maintains $101...

Beyond The Numbers: 20 Analysts Discuss Re...
09/09/2024 14:00:28

RBC Capital Maintains Outperform on Regene...
09/09/2024 13:57:15

RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Outperform and raises the price ...

RBC Capital Reiterates Outperform on Regen...
09/05/2024 16:36:02

RBC Capital analyst Brian Abrahams reiterates Regeneron Pharmaceuticals (NASDAQ:REGN) with a Outperform and maintains $1250 ...

Evaluating Regeneron Pharmaceuticals Again...
08/27/2024 15:00:33

$regeneron-says-european-commission-has-approved-ordspono-to-treat-adult-patients-with-relapsed-or-refractory-follicular-lymphoma-or-rr-diffuse-large-b-cell-lymphoma-after-two-or-more-lines-of-systemic-therapy$

Regeneron Says European Commission Has App...
08/26/2024 11:09:03

This marks the first regulatory approval of Ordspono in the world for these patients. Ordspono is a bispecific antibody that ac...

Regeneron Highlights Scientific Innovation...
08/26/2024 05:48:23

20 abstracts, including 4 oral presentations, offer new treatment insights for chronic obstructive pulmonary disease (COPD), ...

What Analysts Are Saying About Regeneron P...
08/23/2024 15:00:19

Piper Sandler Maintains Overweight on Rege...
08/23/2024 14:26:11

Piper Sandler analyst Christopher Raymond maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the...

regeneron-faces-setback-with-fda-rejection-of-blood-cancer-treatment

Regeneron Faces Setback With FDA Rejection...
08/21/2024 01:26:50

Regeneron Pharmaceuticals Inc. has received a setback as the Food and Drug Administration has declined its application for a bl...

if-you-invested-1000-in-this-stock-20-years-ago-you-would-have-130-thousand-today

If You Invested $1000 In This Stock 20 Yea...
08/20/2024 20:30:12

Insights Into Regeneron Pharmaceuticals's ...
08/13/2024 15:00:34

100-invested-in-this-stock-20-years-ago-would-be-worth-15000-today

$100 Invested In This Stock 20 Years Ago W...
08/08/2024 15:30:34

JP Morgan Maintains Overweight on Regenero...
08/02/2024 20:48:25

JP Morgan analyst Chris Schott maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the price targ...

RBC Capital Maintains Outperform on Regene...
08/02/2024 20:36:15

RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Outperform and raises the price ...

Guggenheim Maintains Buy on Regeneron Phar...
08/02/2024 19:14:58

Guggenheim analyst Yatin Suneja maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target fro...

Wells Fargo Maintains Overweight on Regene...
08/02/2024 18:29:51

Wells Fargo analyst Mohit Bansal maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the price ta...

Barclays Maintains Overweight on Regeneron...
08/02/2024 15:32:32

Barclays analyst Carter Gould maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the price targe...

Analyst Ratings For Regeneron Pharmaceuticals
08/02/2024 14:01:18

Truist Securities Reiterates Buy on Regene...
08/02/2024 13:21:59

Truist Securities analyst Srikripa Devarakonda reiterates Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the ...

Notes From The Street: 'FLASHBACK....Oil G...
01/13/2015 13:20:41